Cargando…

Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy

The role of previous thoracic radiation therapy as a risk factor of immune‐related pneumonitis is unclear. Furthermore, some patients develop radiation recall pneumonitis, which is characterized by a radiation pneumonitis‐like imaging pattern with consolidation progressing within a previous radiatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noda‐Narita, Shoko, Naito, Tomoyuki, Udagawa, Hibiki, Goto, Koichi, Miyawaki, Taichi, Mamesaya, Nobuaki, Nakashima, Kazuhisa, Kenmotsu, Hirotsugu, Shimokawaji, Tadasuke, Kato, Terufumi, Hakozaki, Taiki, Okuma, Yusuke, Nakamura, Masaki, Nakayama, Yuko, Watanabe, Hirokazu, Kusumoto, Masahiko, Ohe, Yuichiro, Horinouchi, Hidehito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899626/ https://www.ncbi.nlm.nih.gov/pubmed/36285515 http://dx.doi.org/10.1111/cas.15621

Ejemplares similares

Radiation recall pneumonitis induced by nivolumab in a patient with renal cell carcinoma
por: Nakamura, Kenji, et al.
Publicado: (2018)

Tozinameran: Radiation recall pneumonitis: case report
Publicado: (2022)

Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy
por: Doshita, Kosei, et al.
Publicado: (2022)

Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review
por: McGovern, Kerri, et al.
Publicado: (2019)

Radiation recall pneumonitis after COVID‐19 vaccination
por: Shinada, Kanako, et al.
Publicado: (2021)

Radiation Recall Pneumonitis During Systemic Treatment With Everolimus
por: Clark, Douglas, et al.
Publicado: (2015)

Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer
por: Inoue, Hiroto, et al.
Publicado: (2020)

Radiation Recall Pneumonitis: A Rare Syndrome That Should Be Recognized
por: Jan, Pei-Rung, et al.
Publicado: (2022)

Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer
por: Nishimura, Ari, et al.
Publicado: (2021)

Radiation recall pneumonitis from immune checkpoint inhibitors after extra pulmonary radiation
por: Kao, Leslie E., et al.
Publicado: (2023)

Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
por: Mamesaya, Nobuaki, et al.
Publicado: (2017)

Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer
por: Torresan, Sara, et al.
Publicado: (2023)

Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer
por: Ding, Xiao, et al.
Publicado: (2011)

Radiation Recall Pneumonitis Induced by Sintilimab: A Case Report and Literature Review
por: Wang, Min, et al.
Publicado: (2022)

A Case of Suspected Radiation Recall Pneumonitis After a COVID-19 Infection
por: Kurosaki, Hiromasa, et al.
Publicado: (2021)

Radiation Recall Pneumonitis: The Open Challenge in Differential Diagnosis of Pneumonia Induced by Oncological Treatments
por: Grassi, Francesca, et al.
Publicado: (2023)

Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
por: Kashihara, Tairo, et al.
Publicado: (2020)

Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
por: Lu, Xiaotong, et al.
Publicado: (2022)

Rapid Development of Clinically Symptomatic Radiation Recall Pneumonitis Immediately Following COVID-19 Vaccination
por: Steber, Cole R, et al.
Publicado: (2021)

Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications
por: Teng, Feifei, et al.
Publicado: (2020)

Radiation Recall Pneumonitis Induced by Anti-PD-1 Blockade: A Case Report and Review of the Literature
por: Chen, Yu, et al.
Publicado: (2020)

Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature
por: Riviere, Paul, et al.
Publicado: (2021)

RADIATION RECALL PNEUMONITIS COVID-19 INDUCED AFTER ADJUVANT BREAST CANCER RADIOTHERAPY: A CASE REPORT
por: LAZZARI, G., et al.
Publicado: (2022)

An open-label feasibility study of nintedanib combined with docetaxel in Japanese patients with locally advanced or metastatic lung adenocarcinoma after failure of first-line chemotherapy
por: Yamamoto, Noboru, et al.
Publicado: (2018)

Relationship between radiation doses to heart substructures and radiation pneumonitis in patients with thymic epithelial tumors
por: Tomita, Natsuo, et al.
Publicado: (2020)

Radiation Recall with Anticancer Agents
por: Burris, Howard A., et al.
Publicado: (2010)

Pectoralis major radiation recall
por: Hack, Emma, et al.
Publicado: (2018)

Effects of diabetes on the development of radiation pneumonitis
por: Dong, Guangtong, et al.
Publicado: (2021)

Treatment and relapse of interstitial lung disease in nivolumab‐treated patients with non–small cell lung cancer
por: Sata, Masafumi, et al.
Publicado: (2021)

Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non–small cell lung cancer
por: Saito, Yoshinobu, et al.
Publicado: (2021)

Radiation recall reaction causing cardiotoxicity
por: Masri, Sofia Carolina, et al.
Publicado: (2014)

Nitrofurantoin-induced radiation recall dermatitis
por: Garrahy, Ian, et al.
Publicado: (2019)

Radiation recall dermatitis induced by ibuprofen()
por: Zhang, Li-wen, et al.
Publicado: (2023)

Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer
por: Nishioka, Naoya, et al.
Publicado: (2020)

Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non‐small cell lung cancer harboring EGFR mutation
por: Kodama, Hiroaki, et al.
Publicado: (2021)

Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular vesicles
por: Torasawa, Masahiro, et al.
Publicado: (2023)

A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis
por: Ikeda, Satoshi, et al.
Publicado: (2020)

Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report
por: Ye, Xianghua, et al.
Publicado: (2022)

Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
por: Hsieh, Chen-Hsi, et al.
Publicado: (2014)

Radiation Pneumonitis after Radiotherapy of Neck Lymphoma
por: Wei, Min, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1tuhi2jshc2d2827am6nuobhna